Literature DB >> 16608349

Crystal structures of Salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of beta-lactone ring opening and a mechanism for irreversible binding.

Michael Groll1, Robert Huber, Barbara C M Potts.   

Abstract

The crystal structures of the yeast 20S proteasome core particle (CP) in complex with Salinosporamides A (NPI-0052; 1) and B (4) were solved at <3 angstroms resolution. Each ligand is covalently bound to Thr1O(gamma) via an ester linkage to the carbonyl derived from the beta-lactone ring of the inhibitor. In the case of 1, nucleophilic addition to the beta-lactone ring is followed by addition of C-3O to the chloroethyl group, giving rise to a cyclic ether. The crystal structures were compared to that of the omuralide/CP structure solved previously, and the collective data provide new insights into the mechanism of inhibition and irreversible binding of 1. Upon opening of the beta-lactone ring, C-3O assumes the position occupied by a water molecule in the unligated enzyme and hinders deacylation of the enzyme-ligand complex. Furthermore, the resulting protonation state of Thr1NH2 deactivates the catalytic N-terminus.

Entities:  

Year:  2006        PMID: 16608349     DOI: 10.1021/ja058320b

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  81 in total

Review 1.  Salinosporamide natural products: Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics.

Authors:  Tobias A M Gulder; Bradley S Moore
Journal:  Angew Chem Int Ed Engl       Date:  2010-12-03       Impact factor: 15.336

2.  Selective overproduction of the proteasome inhibitor salinosporamide A via precursor pathway regulation.

Authors:  Anna Lechner; Alessandra S Eustáquio; Tobias A M Gulder; Mathias Hafner; Bradley S Moore
Journal:  Chem Biol       Date:  2011-12-23

3.  The discovery of salinosporamide K from the marine bacterium "Salinispora pacifica" by genome mining gives insight into pathway evolution.

Authors:  Alessandra S Eustáquio; Sang-Jip Nam; Kevin Penn; Anna Lechner; Micheal C Wilson; William Fenical; Paul R Jensen; Bradley S Moore
Journal:  Chembiochem       Date:  2011-01-03       Impact factor: 3.164

4.  Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules.

Authors:  Celia R Berkers; Annemieke de Jong; Karianne G Schuurman; Carsten Linnemann; Hugo D Meiring; Lennert Janssen; Jacques J Neefjes; Ton N M Schumacher; Boris Rodenko; Huib Ovaa
Journal:  J Immunol       Date:  2015-09-23       Impact factor: 5.422

Review 5.  Leveraging ecological theory to guide natural product discovery.

Authors:  Michael J Smanski; Daniel C Schlatter; Linda L Kinkel
Journal:  J Ind Microbiol Biotechnol       Date:  2015-10-05       Impact factor: 3.346

Review 6.  Proteasome inhibitors: an expanding army attacking a unique target.

Authors:  Alexei F Kisselev; Wouter A van der Linden; Herman S Overkleeft
Journal:  Chem Biol       Date:  2012-01-27

7.  Concise total synthesis of (+/-)-salinosporamide A, (+/-)-cinnabaramide A, and derivatives via a bis-cyclization process: implications for a biosynthetic pathway?

Authors:  Gil Ma; Henry Nguyen; Daniel Romo
Journal:  Org Lett       Date:  2007-05-04       Impact factor: 6.005

8.  A phase 1 dose escalation study of the safety and pharmacokinetics of the novel proteasome inhibitor carfilzomib (PR-171) in patients with hematologic malignancies.

Authors:  Owen A O'Connor; A Keith Stewart; Marcy Vallone; Christopher J Molineaux; Lori A Kunkel; John F Gerecitano; Robert Z Orlowski
Journal:  Clin Cancer Res       Date:  2009-11-10       Impact factor: 12.531

9.  Detection, distribution, and organohalogen compound discovery implications of the reduced flavin adenine dinucleotide-dependent halogenase gene in major filamentous actinomycete taxonomic groups.

Authors:  Peng Gao; Ying Huang
Journal:  Appl Environ Microbiol       Date:  2009-05-15       Impact factor: 4.792

10.  Covalent complexes of proteasome model with peptide aldehyde inhibitors MG132 and MG101: docking and molecular dynamics study.

Authors:  Siwei Zhang; Yawei Shi; Hongwei Jin; Zhenming Liu; Liangren Zhang; Lihe Zhang
Journal:  J Mol Model       Date:  2009-05-14       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.